Advanced search

You are trying to reach document intended for healthcare professionals only

Letters to HCPs

{pdf_link}

Patient targeted, educational materials

{healthcare_pro_orange} For Healthcare Professionals
In line with the agreed Risk Management Plan for Rimmyrah 10 mg/ml solution for injection - PLGB 44570/0033, Qilu Pharma have developed a set of patient targeted, educational materials in order to support the safe use of ranibizumab.

Are you a healthcare professional?